$7.00
-1.08-13.37%
Last update: Nov 5, 4:00 PM
Kazia Therapeutics Ltd
KZIANASDAQ
The average analyst price target for Kazia Therapeutics is $27.10, 236.6% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $15 to $40. The latest change came on Oct 30, 2026, when Needham initiated coverage of Kazia Therapeutics with a Buy rating and a $27 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
